Campbell Brothers targets Scandinavian market
Australian-owned Campbell Brothers has entered the Scandinavian laboratory market by acquiring Swedish-based lab group Analytica.
Archives for August 9, 2006
Quintiles returns investment to US soil
Quintiles has turned its latest investment back towards home soil, announcing plans to open a new US clinical data processing centre in Williamston, North Carolina.
Changing a drug to match a drug delivery technology
When selecting a pharmaceutical formulation, the conventional wisdom has been to manipulate a drug delivery platform to make it compatible with a drug's properties, yet the opposite approach may have several benefits if enough thought is put into it...
Lonza losing out to Asian competition
While Lonza's biopharmaceutical business has taken off, tough competition from cheap Asian competitors is eating away at its exclusive synthesis business - meanwhile, the whole business is being hit by rising raw material and energy costs.
Further lab investment reflects iNovacia growth
Contract research organisation iNovacia is expanding its compound library by increasing the number of compound storage modules in a bid to cope with new contracts.
New test to identify patients at low blood clot risk
Researchers have found that a simple and inexpensive test can help determine which patients with venous thromboembolism (VTE) are at low risk for recurrence and can therefore avoid unnecessary and potentially dangerous long-term anticoagulant treatment.
Seeing through formulation problems
Drug manufacturers are increasingly turning to specialised providers of analytical services for the solid state characterisation of their formulations, seeking answers to processing issues, drug delivery challenges and even protecting drug patents.